These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26391572)

  • 21. High-level expression of Hsp90β is associated with poor survival in resectable non-small-cell lung cancer patients.
    Kim SH; Ji JH; Park KT; Lee JH; Kang KW; Park JH; Hwang SW; Lee EH; Cho YJ; Jeong YY; Kim HC; Lee JD; Jang I; Lee JS; Lee HW; Lee GW
    Histopathology; 2015 Oct; 67(4):509-19. PubMed ID: 25704653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
    Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
    Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.
    Zhu J; Li Q; He JT; Liu GY
    Int J Clin Exp Pathol; 2015; 8(12):15801-7. PubMed ID: 26884850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
    Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
    Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
    Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
    Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDC25B: relationship with angiogenesis and prognosis in non-small cell lung carcinoma.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Fontanini G
    Hum Pathol; 2007 Oct; 38(10):1563-8. PubMed ID: 17651784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.
    Takahashi Y; Ishii G; Taira T; Fujii S; Yanagi S; Hishida T; Yoshida J; Nishimura M; Nomori H; Nagai K; Ochiai A
    J Thorac Oncol; 2011 Sep; 6(9):1460-7. PubMed ID: 21849853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical significance of FSCN1 in non-small cell lung cancer.
    Luo A; Yin Y; Li X; Xu H; Mei Q; Feng D
    Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma.
    Imoto H; Osaki T; Taga S; Ohgami A; Ichiyoshi Y; Yasumoto K
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1007-14. PubMed ID: 9605068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
    Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
    Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
    Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
    Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
    Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.